Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records
Authors
Elena Raffetti (ORCID: https://orcid.org/0000-0001-8742-3986)
Chief Scientist Office, Scottish Government Health and Social Care Directorate
American Regent
Medical Research Council
Engineering and Physical Sciences Research Council
Economic and Social Research Council
Health and Social Care Research and Development Division
Relypsa
NIHR Cambridge Biomedical Research Centre
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records
Elena Raffetti, Angela Wood, Emanuele Di Angelantonio, Claire Lawson et al.
Citations
14 citations
Journal
The Lancet Public Health
Topics
Heart Failure Treatment and Management
Field-Weighted Citation Impact (FWCI)
5.63
article
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records
Elena Raffetti, Angela Wood, Emanuele Di Angelantonio, Claire Lawson, Brendon Lange Neuen, John G.F. Cleland, Robert A. Fletcher, Nathalie Conrad, John J.V. McMurray, Theresa A. McDonagh, Luigi Filippo Brizzi, John Danesh, Glenn M. Chertow, Christopher Tomlinson, Stelios Boulitsakis Logothetis, Clare Arnott, Patrick Rockenschaub, Carmen Petitjean, Muthiah Vaduganathan, Patrick A. Calvert, Mehrdad A. Mizani, Amitava Banerjee, Spiros Denaxas, Johan Sundström, Iain Squire, Ingrid Walter, Cathie Sudlow, Kamlesh K. Khunti, Stephen Kaptoge, Thomas Bolton, Mamas Mamas, Steffen E Petersen
article en
14 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Public HealthVol. 9(11)
Institutions
Brigham and Women's Hospital (US), Harvard University (US), Innsbruck Medical University (AT), University of Leicester (GB), Universität Innsbruck (AT), Glenfield Hospital (GB), British Heart Foundation (GB), Keele University (GB), University of Glasgow (GB), Stanford University (US)
Funders
Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Alnylam Pharmaceuticals, Regeneron Pharmaceuticals, Wellcome Trust, Scottish Government, Alan Turing Institute, Government of the United Kingdom, Cytokinetics, Impulse Dynamics, National Institute for Health and Care Research, British Heart Foundation, Department of Health and Social Care, University of Glasgow, Public Health Agency, Fondation Leducq, Linköpings Universitet, Karolinska Institutet, Novo Nordisk, Vifor Pharma, Uppsala Universitet, Servier, Sun Pharma, Ipsen, Region Uppsala, Chief Scientist Office, Scottish Government Health and Social Care Directorate, American Regent, Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Health and Social Care Research and Development Division, Relypsa, NIHR Cambridge Biomedical Research Centre